Architecture Monthly Magazine: Biopharma
AWS Architecture BlogArchitecture Monthly Magazine: Biopharmaby Jane Scolieri | on14 APR 2021| inArchitecture,Healthcare,Life Sciences|Permalink|ShareFrom R&D through commercialization, biopharma organizations are lookingto bring advanced and differentiated therapeutics to market faster. For example, the Moderna mRNA vaccine was developed and approved for emergency use in record time compared to past vaccines.AWS is the secure, trusted technology partner to help the highly regulated biopharma industry confidently increase the pace of innovation, unlock the potential of scientific data, and develop a more streamlined approach to therapeutic development.In this issue, we’ll look at some of the architectural patterns, processes, and services available for scientific research, drug manufacturing, compliance, and scaling. We hope you’ll find this edition of Architecture Monthly useful. We’d like to thank Kelli Jonakin, PhD, Global Head of Life Sciences & Genomics Marketing, AWS, as well as our Expert, Patrick Combes, Tech Leader, Healthcare and Life Sciences for their contributions.Please give us your feedback! Include your comments on the Amazon Kindle page. You can view past issues and reach out to aws-architecture-monthly@amazon.com anytime with your questions and comments.In this month’s Biopharma issue:Ask an Expert:Patrick Combes, Tech Director, Healthcare and Life Sciences, AWSCase Study:Inspire Uses ML to Connect Millions of Patients and Caregivers on AWSQuick Start:AWS Biotech Blueprint – CoreBlog:AWS and Novartis: Re-inventing pharma manufacturingExecutive Summary:Why AWS for GxP regulated workloads?Reference Architecture:GxP Compliance AutomationSolution:Service Workbench on AWSCase Study:Bristol Myers Squibb Builds Enterprise Data Lakes on AWSTraining:Intro to Healthcare and Life Sciences (HCLS) Compliance on AWSReference Architecture:Patient Engagement with Amazon Pinpoint and Amazon PersonalizeBlog:Executive Conversations: Accelerating COVID-19 vaccine development with Marcello Damiani, Chief Digital and Operational Excellence Officer at ModernaExecutive Brief:Biopharma on AWSReference Architecture:Lab instrument log acquisition and analyticsRelated Videos:Streamline Innovation in Biopharma with AWSEvidation Health Enables Next Generation Clinical Studies on AWSPwC: Building an Efficient, Intelligent, Serverless Pipeline for the Pharma IndustryBristol-Myers Squibb: Enabling DevOps with AWS Service CatalogPodcast:AWS Innovation with EB ResearchDownload the MagazineHow to access the magazineView and download past issues as PDFs on theAWS Architecture Monthlywebpage.Readers in theUS,UK,Germany, andFrancecan subscribe to the Kindle version of the magazine atKindle Newsstand.VisitFlipboard, a personalized mobile magazine app that you can also read on your computer.We hope you’re enjoying Architecture Monthly, and we’d like to hear from you—leave us a star rating and comment on theAmazon Kindle Newsstandpage or contact us anytime at aws-architecture-monthly@amazon.com.TAGS:Architecture,Biopharma,Healthcare and Life SciencesJane ScolieriJane is UX Producer for the AWS Product Mktng team, and working on AWS TV. She lives in beautiful Seattle.
From R&D through commercialization, biopharma organizations are looking to bring advanced and differentiated therapeutics to market faster. For example, the Moderna mRNA vaccine was developed and approved for emergency use in record time compared to past vaccines. AWS is the secure, trusted technology partner to help the highly regulated biopharma industry confidently increase the pace […]
Jane Scolieri
Architecture Healthcare Life Sciences